Philippe Devillier

8.9k total citations
228 papers, 5.2k citations indexed

About

Philippe Devillier is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Philippe Devillier has authored 228 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Physiology, 73 papers in Pulmonary and Respiratory Medicine and 40 papers in Molecular Biology. Recurrent topics in Philippe Devillier's work include Asthma and respiratory diseases (94 papers), Allergic Rhinitis and Sensitization (38 papers) and Respiratory and Cough-Related Research (31 papers). Philippe Devillier is often cited by papers focused on Asthma and respiratory diseases (94 papers), Allergic Rhinitis and Sensitization (38 papers) and Respiratory and Cough-Related Research (31 papers). Philippe Devillier collaborates with scholars based in France, Germany and United States. Philippe Devillier's co-authors include Emmanuel Naline, Stanislas Grassin‐Delyle, Germain Bessard, Charles Advenier, Christophe Faisy, Pascal Demoly, Hélène Salvator, D. Regoli, Marion Brollo and Louis‐Jean Couderc and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Philippe Devillier

220 papers receiving 5.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philippe Devillier France	40	2.2k	1.3k	1.2k	983	528	228	5.2k
Fabio Luigi Massimo Ricciardolo Italy	39	3.1k 1.4×	2.3k 1.8×	559 0.5×	910 0.9×	149 0.3×	162	5.4k
César Picado Spain	49	4.4k 2.0×	2.8k 2.1×	2.4k 1.9×	601 0.6×	393 0.7×	329	8.6k
C. G. A. Persson Sweden	52	4.8k 2.1×	3.4k 2.6×	1.7k 1.4×	1.2k 1.2×	256 0.5×	248	8.3k
Barbro Dahlén Sweden	47	4.8k 2.1×	3.0k 2.3×	1.9k 1.5×	711 0.7×	320 0.6×	148	7.1k
David H. Eidelman Canada	43	2.3k 1.0×	2.2k 1.6×	414 0.3×	900 0.9×	101 0.2×	157	5.1k
Ákos Heinemann Austria	54	1.8k 0.8×	697 0.5×	705 0.6×	1.8k 1.8×	215 0.4×	214	7.2k
Johan Kips Belgium	37	3.7k 1.7×	2.3k 1.7×	1.1k 0.9×	494 0.5×	171 0.3×	101	5.1k
Malcolm Johnson United Kingdom	40	3.9k 1.8×	3.2k 2.4×	564 0.5×	1.2k 1.2×	97 0.2×	84	6.1k
Keith J. Simons Canada	35	1.4k 0.6×	487 0.4×	2.2k 1.8×	389 0.4×	714 1.4×	89	4.1k
Masakazu Ichinose Japan	45	3.3k 1.5×	4.0k 3.1×	308 0.3×	1.5k 1.5×	74 0.1×	261	7.3k

Countries citing papers authored by Philippe Devillier

Since Specialization

Citations

This map shows the geographic impact of Philippe Devillier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Devillier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Devillier more than expected).

Fields of papers citing papers by Philippe Devillier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Devillier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Devillier. The network helps show where Philippe Devillier may publish in the future.

Co-authorship network of co-authors of Philippe Devillier

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Devillier. A scholar is included among the top collaborators of Philippe Devillier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Devillier. Philippe Devillier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zielen, Stefan, Hartmut Richter, Petra Zieglmayer, et al.. (2025). Long-term impact of a birch/alder/hazel or birch-only liquid sublingual immunotherapy on birch-family pollen respiratory allergy: A real-world study. Allergology International. 74(4). 572–578.

Demoly, Pascal, Mathiéu Molimard, Jean‐François Bergmann, et al.. (2024). Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study). The Lancet Regional Health - Europe. 41. 100915–100915. 12 indexed citations

Salvator, Hélène, et al.. (2024). Therapeutic drug monitoring of corticosteroids/β2-agonists in the hair of patients with asthma: an open-label feasibility study. Frontiers in Pharmacology. 14. 1339835–1339835. 1 indexed citations

Pfaar, Oliver, Philippe Devillier, Jochen Schmitt, et al.. (2023). Adherence and persistence in allergen immunotherapy (APAIT): A reporting checklist for retrospective studies. Allergy. 78(8). 2277–2289. 4 indexed citations

Pfaar, Oliver, et al.. (2023). Clinical relevance of pre‐ and coseasonal sublingual immunotherapy with a 300 index of reactivity 5‐grass SLIT tablet in allergic rhinoconjunctivitis. Clinical and Translational Allergy. 13(12). e12321–e12321. 2 indexed citations

Suehs, Carey, M. Zysman, Cécile Chenivesse, et al.. (2020). Prioritising outcomes for evaluating eosinophil-guided corticosteroid therapy among patients with acute COPD exacerbations requiring hospitalisation: a Delphi consensus study. BMJ Open. 10(7). e035811–e035811. 3 indexed citations

Devillier, Philippe, Marc Humbert, Loretta Jacques, et al.. (2018). Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting β2-agonists (ICS/LABA) in patients with uncontrolled asthma: An open-label, randomized, controlled trial. Respiratory Medicine. 141. 111–120. 11 indexed citations

Devillier, Philippe, Hélène Salvator, Emmanuel Naline, Louis‐Jean Couderc, & Stanislas Grassin‐Delyle. (2017). Metabolomics in the Diagnosis and Pharmacotherapy of Lung Diseases. Current Pharmaceutical Design. 23(14). 2050–2059. 15 indexed citations

Victoni, Tatiana, Thomas Gicquel, Hermann Tenor, et al.. (2015). Roflumilast n-oxide associated with PGE2 prevents the neutrophil elastase-induced production of chemokines by epithelial cells. International Immunopharmacology. 30. 1–8. 8 indexed citations

10.

Morélot-Panzini, Capucine, Hélène Gilet, B. Aguilaniu, et al.. (2014). Multidimensional evaluation of dyspnea in COPD: An observational field-study. European Respiratory Journal. 44(Suppl 58). P2182–P2182. 1 indexed citations

11.

Morélot-Panzini, Capucine, Hélène Gilet, B. Aguilaniu, et al.. (2014). Dyspnea as the major driver of anxiety in amyotrophic lateral sclerosis. European Respiratory Journal. 44(Suppl 58). P2190–P2190.

12.

Howarth, Peter, Hans‐Jørgen Malling, Mathiéu Molimard, & Philippe Devillier. (2011). Analysis of allergen immunotherapy studies shows increased clinical efficacy in highly symptomatic patients. Allergy. 67(3). 321–327. 43 indexed citations

13.

Buenestado, Amparo, Stanislas Grassin‐Delyle, Emmanuel Naline, et al.. (2011). Roflumilast inhibits the release of chemokines and TNF‐α from human lung macrophages stimulated with lipopolysaccharide. British Journal of Pharmacology. 165(6). 1877–1890. 62 indexed citations

14.

Horak, Friedrich, Petra Zieglmayer, René Zieglmayer, et al.. (2009). Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber. Journal of Allergy and Clinical Immunology. 124(3). 471–477.e1. 143 indexed citations

15.

Devillier, Philippe, et al.. (2009). Tiotropium reduction of lung inflammation in a model of chronic gastro-oesophageal reflux. European Respiratory Journal. 35(6). 1370–1376. 34 indexed citations

16.

Pradalier, A, Catherine Neukirch, I. Dreyfus, & Philippe Devillier. (2007). Desloratadine improves quality of life and symptom severity in patients with allergic rhinitis. Allergy. 62(11). 1331–1334. 35 indexed citations

17.

Devillier, Philippe & Jean Bousquet. (2007). Inhibition of the histamine‐induced weal and flare response: a valid surrogate measure for antihistamine clinical efficacy?. Clinical & Experimental Allergy. 37(3). 400–414. 23 indexed citations

18.

Cracowski, Jean‐Luc, Carmine Sessa, Mark Jeremy Hunt, et al.. (2000). Vasoconstrictor Effects of Iso-Prostaglandin F2α Type-III (8-Iso-Prostaglandin F2α) on Human Saphenous Veins. Journal of Cardiovascular Pharmacology. 35(5). 729–734. 17 indexed citations

19.

Stanke‐Labesque, Françoise, et al.. (1999). Functional assessment of rat aorta after cold storage in different media. Fundamental and Clinical Pharmacology. 13(3). 310–319. 18 indexed citations

20.

Devillier, Philippe, et al.. (1986). Histamine Release and Local Responses of Rat and Human Skin to Substance P and Other Mammalian Tachykinins. Pharmacology. 32(6). 340–347. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact